Pharma Industry
Industry: Email Alert RSS FeedASTRAZENECA.(Brief Article)(Statistical Data Included)
Chemical Market Reporter, February, 2001
ASTRAZENECA has filed a lawsuit against Impax Laboratories alleging patent infringement relating to Impax Laboratories Inc.'s filing of an abbreviated new drug application for a generic version of Prilosec (omeprazole) 40 mg delayed-release capsules. Impax says that FDA had accepted the company's ANDA for a generic version of Prilosec and that it believes there is no patent infringement.
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Presented by American Express